Concepedia

Hans Matter

HM

76

Publications

4.2K

Citations

36

H-Index

1991

Active since

Affiliations

Sanofi (Germany)(Current)

Sanofi (France)

Technical University of Munich

LETI Pharma (Germany)

Hans Matter is an author at Sanofi (Germany) specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicineDrug DiscoveryPharmacologyNatural SciencesBiochemistryMedicinal ChemistryChemical BiologyMolecular BiologyMolecular DockingEngineering

Publications per year

1991–2023

76

Publications

76

Targeting DnaN for tuberculosis therapy using novel griselimycins

Angela Kling, Peer Lukat, Deepak V. Almeida et al. · Science · 2015 · 309 citations

Streptomyces-produced Streptomycin, Antibiotic Adjuvant, Tuberculosis Prevention +18

Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity

Hans Matter, Marc Nazaré, Stefan Güssregen et al. · Angewandte Chemie International Edition · 2009 · 267 citations

Selecting Optimally Diverse Compounds from Structure Databases: A Validation Study of Two-Dimensional and Three-Dimensional Molecular Descriptors

Hans Matter · Journal of Medicinal Chemistry · 1997 · 251 citations

Topological Similarity, Molecular Biology, Chemistry +21

Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets

Jan Wenzel, Hans Matter, Friedemann Schmidt · Journal of Chemical Information and Modeling · 2019 · 209 citations

Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols

Andreas Evers, Hans Matter, Thomas Klabunde · Journal of Medicinal Chemistry · 2005 · 182 citations

Rows per page

1–5 of 76